ProShare Advisors’s Achaogen Inc AKAO Stock Holding History

ProShare Advisors’s Portfolio AKAO Stock Details AKAO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-22,279	Closed	-$89K	–	1782
2018 Q3	$89K	Sell	22,279 -683	-3%	-$4.13K	﹤0.01%	1695
2018 Q2	$199K	Sell	22,962 -2,084	-8%	-$25.4K	﹤0.01%	1616
2018 Q1	$324K	Sell	25,046 -2,865	-10%	-$32.5K	﹤0.01%	1281
2017 Q4	$300K	Buy	+27,911	New	+$350K	﹤0.01%	1389

Other funds holding AKAO

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ProShare Advisors's AKAO Position: Q4 2018 in Review

ProShare Advisors sold out of Achaogen Inc (AKAO) in Q4 2018, closing a stake of 22,279 shares — an estimated $89K sold.

ProShare Advisors first reported a position in AKAO in Q4 2017 and held it in 4 quarters. The position peaked at $324K in Q1 2018. 78 funds tracked by Wall St. Rank hold AKAO as of Q4 2018.

ProShare Advisors reported no remaining Achaogen Inc position as of Q4 2018 after selling out during the quarter.
ProShare Advisors sold 22,279 Achaogen Inc shares in Q4 2018, an estimated $89K.
ProShare Advisors first reported a position in Achaogen Inc in Q4 2017 and held it in 4 quarters.
ProShare Advisors's Achaogen Inc position peaked at $324K in Q1 2018.
78 funds tracked by Wall St. Rank held Achaogen Inc as of Q4 2018.

Based on ProShare Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.